Compuestos fenólicos y su efecto en las dislipidemias en seres humanos: Una revisión sistemática

Abstract

Deaths from heart disease and other cardiovascular diseases have increased in recent decades. Among the main factors that lead to the development of heart disease is dyslipidemia, which are disorders that directly affect the blood supply through the development of atheroma in the cardiovascular system. It has been proposed that phenolic compound intake has an important antilipidemic effect, a fact that suggests a preventive and protective characteristic against these diseases. The objective of this work is to present an analysis of the information related to treatment that includes the use of phenolic compounds on dyslipidemia parameters in humans; comparing samples, the components and the results of these types of disorders. Although the number of articles exploring this relationship is diverse, this systematic review explores the data related to a possible beneficial reaction of human metabolism. The search was carried out in two databases: PubMed and Web of Science, where a total of 2229 potential articles were obtained, of which 2194 were excluded, leaving 35 articles for review. Altogether, the results showed that, although there are certain beneficial properties of phenolic compounds such as isoflavones, tannins, theaflavins and anthocyanins that have been proven beneficial for cardiovascular diseases, for dyslipidemia specifically, it is still difficult to combine conclusive results. In these circumstances, the available information indicates the necessity to continue investigating the action of phenolic compounds on these types of pathologies.